Announcements Trials
Browse Landscape

Status

Withdrawn 1Recruiting 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Observational 2

Sponsor

Cancer Type

Plasma cell 21Other hematologic neoplasm 6Lymphoid 5Classical hematology 3Other 2Myeloid 2Head & Neck 2Genitourinary 2Endocrine 2Dermatologic 2CNS 2Thoracic 1Sarcoma 1Other solid neoplasm 1NET 1Gastrointestinal 1Breast 1

Conditions

Obesity 112Neoplasms 43Sexual Dysfunction, Physiological 31Polycystic Ovary Syndrome 27Overweight 18Breast Neoplasms 18Diabetes Mellitus 16Colorectal Neoplasms 16Dyspnea 14Diabetes Mellitus, Type 2 13Obesity, Morbid 12Mucositis 12Constipation 12Depression 11Prostatic Neoplasms 10Lung Neoplasms 10Hypertension 10Pulmonary Disease, Chronic Obstructive 9Non-alcoholic Fatty Liver Disease 9Metabolic Syndrome 9Insulin Resistance 9Motor Activity 8Cardiovascular Diseases 8Renal Insufficiency, Chronic 7Opioid-Induced Constipation 7Heart Failure 7Asthma 7Sarcopenia 6Rectal Neoplasms 6Multiple Myeloma 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Observational × Amyloidosis × Other × Clear all
NCT06539169 2024-11-14

FLOWER: Following Longitudinal Outcomes With Epidemiology for Rare Diseases

xCures

Recruiting
1,000 enrolled
Classical hematologyOtherPlasma cell

Alzheimer Disease, Amyloidosis, Amyotrophic Lateral Sclerosis, Anemia, Sickle Cell, Cystic Fibrosis, Ehlers-Danlos Syndrome, Gaucher Disease, Glycogen Storage Disease Type II, Huntington Disease, Myasthenia Gravis, Gangliosidosis, GM1, alpha-Thalassemia, beta-Thalassemia, Muscular Dystrophy, Duchenne, Insomnia, Fatal Familial, Rare Diseases

NCT02589860 2022-01-10

Analysis of Oral Mucositis in Patient's Undergoing Melphalan Conditioning and Autologous Stem Cell Transplant

Indiana University

Withdrawn
OtherPlasma cell

Amyloidosis, Multiple Myeloma, Stomatitis, Mucositis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡